|
Targeted therapy of pancreatic cancer with in vivo radionuclide generator
|
5R21CA156088-02
|
$216,630
|
$216,630
|
DADACHOVA, EKATERINA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$150,297
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$10,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$10,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$3,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis
|
1R01CA170911-01
|
$346,525
|
$173,263
|
Libutti, Steven
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis
|
1R01CA163907-01A1
|
$364,002
|
$364,002
|
SCHWARTZ, EDWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
5R01CA216248-02
|
$607,904
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanisms of Formation and Progression of Preleukemic Stem Cells
|
5R01CA217092-02
|
$397,371
|
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-06
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$89,987
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$6,891
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$516,602
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Biospecimen Repository
|
5U24CA114734-07
|
$500,745
|
$50,075
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
5U24CA180803-05
|
$8,285,739
|
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer
|
1R21CA164593-01
|
$212,556
|
$212,556
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Chemotherapy-induced MDSCs and antitumor immunity
|
5R01CA215523-02
|
$347,700
|
|
ZHOU, GANG
|
AUGUSTA UNIVERSITY
|
|
An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells
|
1R21CA223715-01
|
$263,953
|
|
SHI, TUJIN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Pediatric Oncology Clinical Research Training Program
|
5K12CA090433-17
|
$827,164
|
|
BLANEY, SUSAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER
|
5R01CA207270-02
|
$362,569
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of KLF4 suppression in pediatric leukemia
|
5R01CA207086-02
|
$370,641
|
|
LACORAZZA, DANIEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Metabolic Regulation in Leukemia-Initatiating Cells
|
5R01CA193235-04
|
$462,191
|
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
|
DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIA
|
5K08CA201611-02
|
$162,148
|
|
RAU, RACHEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Drugging the Undruggable Coactivators using Small Molecule Inhibitors
|
5R01CA207701-02
|
$426,451
|
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and mechanism of FTO in leukemogenesis and drug response
|
5R01CA214965-03
|
$444,571
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Development and validation of a computational prediction model for exogenous neural stem cell migration to sites of brain tumors
|
1R03CA216142-01A1
|
$86,500
|
|
ROCKNE, RUSSELL
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
|
5R01CA201496-03
|
$479,954
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Regulation of Single Strand Annealing Repair of Mammalian Chromosomal Breaks
|
5R01CA197506-03
|
$388,875
|
|
STARK, JEREMY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Control of tumor growth and metastasis by the cytokine TSLP
|
5R01CA182783-05
|
$362,503
|
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
|
5U01CA151925-03
|
$647,718
|
$647,718
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Overcoming resistance to tyrosine kinase inhibitors in lung cancer
|
5R01CA169259-06
|
$361,049
|
|
KOBAYASHI, SUSUMU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-14
|
$328,700
|
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Functional analysis of a tissue context-dependent role for beta-TRCP in lipid metabolism and tumorigenesis
|
9R01CA229307-05A1
|
$374,063
|
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma
|
2R44CA150484-02
|
$1,019,109
|
$1,019,109
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
CXCR3-B-mediated novel growth-inhibitory signals in breast cancer cells
|
1R03CA215926-01A1
|
$88,500
|
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Single-molecule mechanical detection of protein and microRNA cancer biomarkers
|
5R21CA212827-02
|
$248,117
|
$248,117
|
WONG, WESLEY
|
BOSTON CHILDREN'S HOSPITAL
|
|
Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics
|
5U01CA214292-02
|
$685,690
|
|
TIEN, JOE
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
The Role of DLST in Leukemogenesis
|
1R01CA215059-01A1
|
$377,437
|
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
|
5R01CA214880-02
|
$237,158
|
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Defining lineage-specific determinants of K-Ras "addiction" in human cancers
|
4R00CA149169-03
|
$249,000
|
$82,170
|
SINGH, ANURAG
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Support for Specimen Banking in ACOSOG
|
3U24CA114736-07S1
|
$500,000
|
$100,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Support for Specimen Banking in ACOSOG
|
3U24CA114736-07S2
|
$1,500,000
|
$300,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
$403,689
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
ACOSOG Competing Renewal
|
7U10CA076001-16
|
$2,940,780
|
$88,223
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Pancreas for this search: $130,544,511
|